Greece Launches First-Ever Medical Marijuana Plant in Seaside Town
by Bethan Rose
As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access.
Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies.
To explore this issue further, let’s look at the key findings of this groundbreaking new research.
Similar to Veriheal, Nugg MD connects MMJ patients to physicians via telemedicine.
Their newly unleashed powerful study suggests the need for greater access to cannabis-based medical treatments and more robust protection of healthcare professionals exploring these options with their patients. Here’s what the study found:
Nugg MD’s research explored the motivations behind people’s use of medical cannabis, uncovering fascinating insights about why this treatment is increasingly sought-after.
They found that most patients apply for an MMJ card to alleviate the following:
While most medical marijuana patients utilize it to treat one of their state’s listed conditions, a select few are tapping into its potential for treating unlisted ailments.
Perhaps there’s more complexity behind their decision-making process than meets the eye—especially since they likely have to select different conditions depending on what is legally available in their state.
To understand this concept, imagine a cannabis-friendly state makes provisions for eight qualifying conditions:
While a more restrictive state only makes provisions for five:
The problem is, in the more restrictive states, if patients require medical marijuana for autoimmune disorders or PTSD, they have no choice but to present it as “other conditions”—like anxiety, which anyone can experience at any time.
Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access. Although respondents frequently have to choose “other conditions” to meet MMJ requirements, it’s an unfortunate reality for millions due to restrictive laws and policies, further skewing data towards more universally accepted health issues.
Despite ongoing political debates about the limitations of medical marijuana programs, a 2019 study published in the Journal of Patient-Centered Research and Reviews provided further evidence of how MMJ-restrictive states inadvertently impact their patients.
According to the study, individuals living in states where medical cannabis is difficult to access are more likely to resort to prescription drugs to treat chronic pain or other debilitating conditions.
This suggests that not only may MMJ-restrictive states be failing their citizens by denying access to a proven therapy option, but they may also be unknowingly fostering habits that could increase the risks associated with the long-term use of potentially deadly pharmaceutical medications.
Despite the immense potential of cannabis, its status as a Schedule I drug has been an obstacle in furthering research on the plant. In addition to decades-old stigmas attached to it and its users, progress has been stifled by legal factors that are gradually changing through advocacy and patient support.
Furthermore, Nugg MD’s data shows just how vital MMJ access has become in modern society’s health landscape. However, this study speaks to another dire need for the future: better data collection.
Accurate cannabis data has a unique significance, specifically, when it comes to increasing the number of qualifying conditions nationwide and expanding access–something that can benefit everyone, from patients, practitioners, and policymakers alike.
In states that restrict medical cannabis access, patients and doctors are both negatively affected in a number of ways. The study mentioned above makes it clear that restrictive MMJ policies may be exacerbating the problems of opioid abuse and drug overdose deaths in the United States.
As the world moves towards a more accepting view of plant-based medicine, it’s becoming increasingly difficult for lawmakers to justify keeping restrictions in place. Lawmakers should seize this opportunity to make access to MMJ easier and remove the stigma unfairly cast on those seeking relief from their ailments.
Note: The content on this page is for informational purposes only and is not intended to be professional medical advice. Do not attempt to self-diagnose or prescribe treatment based on the information provided. Always consult a physician before making any decision on the treatment of a medical condition.
Consuming alcohol heavily in young adulthood is associated with an increased likelihood of developing alcohol use disorder (AUD), the most widespread substance-related disorder worldwide. Research has already shed light on the effects of individual differences like alcohol sensitivity and cardiovascular responses in predicting binge drinking behaviors and progression to AUD. However, there remains a gap…
Kentucky is once again exploring medical cannabis legalization, D.C. made good on its expungement promises, and Minnesota okayed a psychedelic task force. Let’s dive into this week’s cannanews. Kentucky Inches Toward Medical Cannabis Legalization Earlier this week, Kentucky’s State Senate passed a new proposal that seeks to legalize medical cannabis in the state. Under the…
The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. On Tuesday, January 24, several legislative bills were unveiled by the Japanese government. One of the proposed bills would amend the Cannabis Control Law…
Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. One psychedelic that’s been getting a whole lot of attention lately is psilocybin, an active ingredient in mushroom species that are often called “magic mushrooms.” Psilocybin is a naturally…
Missouri is home to an estimated population of roughly 6 million residents. The state is popular for the agriculture industry, barbecue, and historic landmarks like the Gateway Arch. Missouri borders eight states and is a gateway to adventure in the land of legal cannabis. Six of the eight states surrounding Missouri have very strict cannabis…
At one time, there was a sign coming into Las Vegas that read, “Don’t gamble with marijuana.” In Nevada, possession equals 20…
Maryland and Delaware are exploring their cannabis policies, a Texas representative introduced another decriminalization bill, and New Orleans okayed cannabis-infused seltzers. Let’s…
Who would have thought that cannabis cultivation could be Alaska’s biggest earner? Over the course of the next eight years, marijuana cultivation…